Quarterly report pursuant to Section 13 or 15(d)

Nature of Operations and Basis of Presentation (Details)

v2.4.1.9
Nature of Operations and Basis of Presentation (Details) (USD $)
0 Months Ended
Jun. 03, 2011
Jan. 31, 2015
subsidiary
Nature of operations and basis of presentation    
Number of subsidiaries   0oncs_NumberOfSubsidiaries
OncoSec Medical Therapeutics    
Nature of operations and basis of presentation    
Total purchase price $ 1,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= oncs_OncoSecMedicalTherapeuticsIncorporatedMember